Delivery Order SPE2DR25D3010-SPE2DR26F88FJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $30,520.46 to supply Taltz 80 mg/ml autoinjectors. The award was made on November 28, 2025, with an ultimate completion date of December 1, 2025, under a firm fixed-price contract type with no set-aside designation. The contract will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $80,176.82 delivery order to AmerisourceBergen Drug Corp for Taltz 80 mg/ml auto-injectors (2-pack) with a completion date of November 26, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The delivery...
- The Defense Logistics Agency awarded a delivery order valued at $12,688.26 to AmerisourceBergen Drug Corp for the supply of Taltz 80 mg/ml auto-injectors, with a firm fixed price structure and an ultimate completion date of May 28, 2025. This non-competitive delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999 and extends through December 2026. The contract...
- The Defense Logistics Agency awarded a $18,969.16 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector medication on December 9, 2025, with completion scheduled for December 10, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a $1,749.70 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed price, competitively awarded contract with performance completion scheduled for December 12, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $11,472.46 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a non-set-aside competitively awarded contract with a completion date of November 5, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,408.43 for TALTZ 80 MG/ML AutoInjector on October 29, 2025, with an ultimate completion date of October 30, 2025. This firm fixed price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running through December 2026. The delivery...
- The Defense Logistics Agency awarded a $47,224 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Taltz 80 mg/ml autoinjector medication. This firm fixed-price, competitively awarded contract (with no set-aside designation) is scheduled for completion by December 10, 2025, with performance based in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $22,497.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for TALTZ 80 mg/ml autoinjector supply. This is a firm fixed price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a delivery order valued at $76,320.98 to AmerisourceBergen Drug Corp for Taltz 80 mg/ml autoinjector on April 23, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of April 24, 2025. This delivery order is issued...
- SPE2DR25D3010Indefinite Delivery Contract
- SPE2DR25D3010-SPE2DR26F88FJDelivery Order
The Defense Logistics Agency awarded a $11,017.75 delivery order to AmerisourceBergen Drug Corp for the supply of Taltz 80 mg/ml autoinjector on December 11, 2025, with completion scheduled for December 12, 2025. This is a firm fixed-price, non-set-aside contract executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The company maintains a comprehensive portfolio of pharmaceutical products and medical supplies delivered through the DLA Medical Supply Chain, ranging from brand-name and generic medications to vaccines and specialized medical devices. This particular delivery order for Taltz, a biologic treatment for autoimmune conditions, exemplifies the company's role as a critical vendor supporting the Defense Health Agency and other federal healthcare systems through competitive, firm fixed-price delivery orders under its overarching pharmaceutical prime vendor contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 12/10/25 |